Ozempic Cost Explained: List Price, Coupons, and Insurance

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub — plain-language guidance on GLP-1 therapy, metabolic health, and the genetics behind individual response.

Ozempic is among the most-searched names in the GLP-1 conversation, and questions about its cost dominate that search as of April 2026. The reason the answer feels slippery is simple: no single price applies to everyone. Your monthly total is assembled from insurance rules, the indication your prescriber writes, savings-card eligibility, and pharmacy pricing. This page separates the published list figure from the amount patients in different coverage situations tend to see.

The list price, and why it misleads

As of April 2026, Ozempic lists at approximately $968 to $1,029 per month at U.S. list price, per Novo Nordisk published pricing. That range is a starting reference, not a prediction of your cost. It precedes rebates, plan discounts, manufacturer cards, and pharmacy negotiation, so most insured patients never pay it. Where you land depends on your formulary, prior-authorization status, and the indication documented on the script.

How plans decide what to pay

Commercial coverage of Ozempic follows the indication and the plan's formulary and prior-authorization criteria. GLP-1 receptor agonists prescribed for type 2 diabetes are widely covered by commercial plans. Chronic weight-management coverage is less consistent, commonly requires BMI-based prior authorization, and is excluded altogether by some plans. As of April 2026, Medicare does not cover FDA-approved weight-management drugs for weight alone, though cardiovascular-indication coverage exists for some products. Confirm details with your plan directly.

Discounts worth checking

Manufacturer savings card

Novo Nordisk publishes a savings card that can substantially lower monthly cost for eligible commercially-insured patients. Government coverage — Medicare, Medicaid, TRICARE — is generally excluded, and the card carries monthly and annual caps that change. Check the manufacturer site for current terms before filling.

Coupon platforms

GoodRx and SingleCare publish pharmacy-specific coupon prices. Comparing a few pharmacies near you can reveal a lower cash price, though savings vary by location and are not locked in.

The compounding window, 2024 to 2025

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies were permitted to prepare compounded versions of these molecules. The FDA marked the semaglutide shortage resolved in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window without eliminating all legitimate activity. Compounded products are not identical to FDA-approved brand medications and are priced separately.

What patients typically pay

With a covered indication and a savings card applied, eligible patients may pay as little as $25 per month, subject to plan caps. Without indication coverage, cash cost sits near list price minus any coupon. Uninsured, the cost approaches list price; compounded options through the PlexusDx Weight Management Protocols follow separate published pricing, available as Semaglutide Injection and Semaglutide Oral.

Understanding your metabolic genetics first

Before committing to any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants such as FTO that shape appetite regulation and energy balance. This is trait-level education about how your genes influence metabolic pathways — it does not predict response to any specific medication.

Related reading: Ozempic cost in 2026, Generic Ozempic, and Ozempic side effects.

Frequently Asked Questions

What does Ozempic cost per month?

About $968 to $1,029 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing. That is the pre-insurance range. Coverage, savings cards, and pharmacy pricing can change the counter total substantially, so verify the current amount with your pharmacy before filling.

Will insurance cover Ozempic?

It depends on the plan, formulary, FDA indication on the prescription, and prior authorization. Type 2 diabetes coverage is common among commercial plans; weight-management coverage is more variable. Medicare does not cover weight-alone indications as of April 2026. Confirm how your specific plan treats Ozempic before assuming any price.

Are savings cards or coupons available?

Novo Nordisk publishes a savings card for eligible commercially-insured patients, and platforms like GoodRx list separate discount prices. Government-insurance patients are usually excluded from the manufacturer card, so confirm current eligibility and caps on the manufacturer site at fill time.

Are there lower-cost alternatives?

Licensed compounding pharmacies prepare compounded semaglutide and tirzepatide at separate price points from brand products; these are not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with pricing published on each product page. A PlexusDx provider can discuss whether a compounded protocol fits your goals.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.